As a board-certified pathologist with a specialization in breast pathology, I perform microscopic examination of breast biopsies and surgical specimens and make diagnoses that help guide treatment decisions for our patients. I am proud to be part of the multidisciplinary team providing breast cancer patients with comprehensive and coordinated care.
I am interested in the molecular and genetic mechanisms of breast cancer development, progression, and response to treatments. My current research is focused on triple negative breast carcinoma — a subgroup of breast cancer that does not express estrogen and progesterone receptors, or the human epidermal growth factor receptor 2 (HER2). I also work closely with my colleagues from surgery, medical oncology, and radiation oncology on a variety of clinical studies in breast cancer.